semaglutide digestive blockage lawsuit in louisiana gastrointestinal obstruction attorney Ozempic [May 2026 Update] Louisiana lawmakers are considering a
Description
Can GLP-1 medications reduce cravings for more than food
Our weight loss doctors will explain the benefits and potential side effects of Wegovy to ensure you make informed decisions about your treatment
Hims & Hers announced a $250 million share buyback program, but escalating GLP-1 price competition from Novo Nordisk overshadowed the news
![semaglutide digestive blockage lawsuit in louisiana gastrointestinal obstruction attorney Ozempic [May 2026 Update] Louisiana lawmakers are considering a](https://assets.medpagetoday.net/media/images/106xxx/106535.jpg)
Swiss obesity start up SixPeaks Bio AG has made a good start, announcing a US$30m Series A financing led by Versant Ventures and a US$80m biobucks partnership with AstraZeneca plc.
![semaglutide digestive blockage lawsuit in louisiana gastrointestinal obstruction attorney Ozempic [May 2026 Update] Louisiana lawmakers are considering a](https://omedhealth.com/wp-content/uploads/2025/10/1.png)
Rare disorders and disease progression were not examined
![semaglutide digestive blockage lawsuit in louisiana gastrointestinal obstruction attorney Ozempic [May 2026 Update] Louisiana lawmakers are considering a](https://i.ytimg.com/vi/5fUtIeFoCns/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLAT0uFsIcZYXO4w-72L_W0cwVB_ag)